Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose amoxicillin plus vonoprazan for Helicobacter pylori eradication (10 vs 14 days)
ChiCTR2200059998Phase 4Recruiting
- Sponsor
- Fujian Provincial Hospital
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amoxicillin and vonoprazan in Helicobacter pylori infection (2 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: Helicobacter pylori eradication rate. Started Apr 2022; status: recruiting.
02
Drugs
amoxicillinvonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2200059998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059998.